JAGX Jaguar health - napo and alivus enter new manufacturing and supply agreement for crofelemer on July 9, 2026 - SEC filing - 2026 agreeme

JAGX Jaguar health - napo and alivus enter new manufacturing and supply agreement for crofelemer on July 9, 2026 - SEC filing - 2026 agreement includes minimum purchase commitment for crofelemer by napo - SEC filing - 2026 agreement set to expire on March 31, 2029 - SEC filing